IQVIA uses Real World Data (RWD) to generate insights throughout the drug product lifecycle, from development to after commercialization. The data may be of relevance to optimize clinical trials via more efficient site and patient identification, to understand the disease landscape, to enrich context for market access, to follow-up long term safety and drug utilization patterns, and to support commercial analytics. If necessary, IQVIA can create a combination or enrichment of data assets. IQVIA also helps researchers by standardising and linking disparate RWD data sets to create insightful and analytical output.
IQVIA’s purpose-built infrastructure for RWD is used to lever dedicated applications with embedded intelligence automate processes to improve the quality, consistency, and compliance of data. This empowers researchers to concentrate on interpreting insights, making better decisions, and delivering more value.